Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
51.37
+0.85 (1.68%)
At close: Feb 25, 2026, 4:00 PM EST
51.50
+0.13 (0.25%)
After-hours: Feb 25, 2026, 4:59 PM EST
Moderna Stock Forecast
Stock Price Forecast
The 11 analysts that cover Moderna stock have a consensus rating of "Hold" and an average price target of $33, which forecasts a -35.76% decrease in the stock price over the next year. The lowest target is $18 and the highest is $69.
Price Target: $33 (-35.76%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 12 | 8 | 8 | 9 | 9 | 9 |
| Sell | 4 | 4 | 3 | 3 | 3 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 15 | 13 | 14 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $63 → $69 | Buy | Maintains | $63 → $69 | +34.32% | Feb 23, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $36 → $41 | Hold | Maintains | $36 → $41 | -20.19% | Feb 17, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $25 → $30 | Hold | Maintains | $25 → $30 | -41.60% | Feb 17, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $28 → $35 | Hold | Maintains | $28 → $35 | -31.87% | Feb 17, 2026 |
| UBS | UBS | Strong Buy → Hold Initiates $40 → $34 | Strong Buy → Hold | Initiates | $40 → $34 | -33.81% | Jan 7, 2026 |
Financial Forecast
Revenue This Year
2.07B
from 1.94B
Increased by 6.38%
Revenue Next Year
2.32B
from 2.07B
Increased by 12.33%
EPS This Year
-7.11
from -7.25
EPS Next Year
-5.09
from -7.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.5B | 3.3B | |||
| Avg | 2.1B | 2.3B | |||
| Low | 1.5B | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 26.4% | 58.1% | |||
| Avg | 6.4% | 12.3% | |||
| Low | -22.0% | -23.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -6.28 | -3.36 | |||
| Avg | -7.11 | -5.09 | |||
| Low | -8.20 | -6.56 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.